Illumina Acquires Fluent BioSciences, Enhancing Single-Cell Technology Capabilities; Advances Multiomics Growth Strategy

7/9/24 4:06:14 PM ET

Medical Specialities

Health Care

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ILMN

Date	Price Target	Rating	Analyst
3/4/2025	$130.00 → $90.00	Neutral	Citigroup
2/28/2025	$100.00	Buy → Hold	HSBC Securities
2/10/2025	$130.00 → $100.00	Equal Weight → Underweight	Barclays
2/7/2025	$177.00 → $140.00	Buy → Hold	TD Cowen
12/11/2024	$190.00 → $165.00	Buy → Neutral	Citigroup
11/12/2024	$156.00	Equal-Weight	Morgan Stanley
10/17/2024	$180.00	Hold → Buy	HSBC Securities
8/28/2024		Hold → Buy	Argus